FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 235 filers reported holding FATE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,237,000 | -97.2% | 31,900 | -95.8% | 0.01% | -97.3% |
| Q4 2021 | $44,317,000 | -67.7% | 757,425 | -67.2% | 0.22% | -65.4% |
| Q3 2021 | $136,997,000 | -17.1% | 2,311,398 | +21.3% | 0.64% | -5.3% |
| Q2 2021 | $165,335,000 | +5.5% | 1,905,000 | +0.3% | 0.68% | -13.2% |
| Q1 2021 | $156,655,000 | -42.6% | 1,900,000 | -36.7% | 0.78% | -52.6% |
| Q4 2020 | $272,790,000 | +118.4% | 3,000,000 | -4.0% | 1.64% | +89.9% |
| Q3 2020 | $124,906,000 | +4.0% | 3,125,000 | -10.7% | 0.86% | -10.1% |
| Q2 2020 | $120,085,000 | +80.2% | 3,500,000 | +16.7% | 0.96% | +68.0% |
| Q1 2020 | $66,630,000 | +51.3% | 3,000,000 | +33.3% | 0.57% | +92.6% |
| Q4 2019 | $44,033,000 | +26.0% | 2,250,000 | 0.0% | 0.30% | +12.5% |
| Q3 2019 | $34,943,000 | -31.1% | 2,250,000 | -10.0% | 0.26% | -20.0% |
| Q2 2019 | $50,750,000 | +15.5% | 2,500,000 | 0.0% | 0.33% | 0.0% |
| Q1 2019 | $43,925,000 | +55.6% | 2,500,000 | +13.6% | 0.33% | +59.4% |
| Q4 2018 | $28,226,000 | +226.9% | 2,200,000 | +315.1% | 0.21% | +305.9% |
| Q3 2018 | $8,634,000 | +881.1% | 530,000 | +209.6% | 0.05% | +264.3% |
| Q3 2014 | $880,000 | -43.8% | 171,196 | -31.0% | 0.01% | -39.1% |
| Q2 2014 | $1,566,000 | -41.5% | 248,102 | -9.8% | 0.02% | -56.6% |
| Q1 2014 | $2,679,000 | -21.6% | 275,000 | -49.5% | 0.05% | -25.4% |
| Q4 2013 | $3,418,000 | – | 544,243 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 569,889 | $46,987,000 | 60.92% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,379,064 | $278,604,000 | 36.08% |
| Darwin Global Management, Ltd. | 1,370,133 | $112,967,000 | 22.12% |
| Redmile Group, LLC | 12,957,222 | $1,068,323,000 | 15.05% |
| Copernicus Capital Management, LLC | 8,000 | $660,000 | 10.66% |
| Casdin Capital, LLC | 3,400,000 | $280,330,000 | 8.35% |
| Grosvenor Holdings, L.L.C. | 1,123,576 | $92,639,000 | 6.81% |
| DAFNA Capital Management LLC | 314,360 | $25,919,000 | 6.15% |
| Ally Bridge Group (NY) LLC | 270,000 | $22,262,000 | 4.27% |
| Ghost Tree Capital, LLC | 185,000 | $15,253,000 | 3.58% |